Zimeng Wei
Wuhan University
5 Papers
Zimeng Wei is an academic researcher from Wuhan University. The author has contributed to research in topics: Biology & Cell. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genes.
Hengjing He,Muhammad Jamal,Xingruo Zeng,Yufei Lei,Di Xiao,Zimeng Wei,Chengjie Zhang,Xiaoyu Zhang,Shan Pan,Qianshan Ding,Haiyan Tan,Songping Xie,Qiu-ying Zhang +12 more
TL;DR: The novel oncogenic function of MATR3 in HCC could comprehensively address how aberrant changes in the cell cycle promote HCC development and might serve as a prognostic predictor and therapeutic target for HCC patients.
3
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis
Muhammad Jamal,Yufei Lei,Hengjing He,Xingruo Zeng,Zimeng Wei,Di Xiao,Liang Shao,Fuling Zhou,Quiping Zhang +8 more
TL;DR: In this article , the authors compared the leukemogenic potentials of two commonly used T-ALL cell lines, MOLT4 and JURKAT, in NOD-PrkdcscidIL2rgdull (NTG) mice and found that MOLTs possessed a relatively higher aggressive phenotype characterized by their enhanced tissue infiltration as compared to the JURkats cells.
Comprehensive assessment of cellular senescence in the tumor microenvironment
Xiaoman Wang,Lifei Ma,Xiaoyan Pei,Heping Wang,Xiaoqiang Tang,Jian-Fei Pei,Yang-Nan Ding,Siyao Qu,Zimeng Wei,Hui-Yu Wang,Xiaoyue Wang,Gong-Hong Wei,De-Pei Liu,Hou-Zao Chen +13 more
TL;DR: This study defined computational metrics of senescence levels as CS scores to delineate CS landscape across 33 cancer types and 29 normal tissues and explored CS-associated phenotypes by integrating multiplatform data from ~20 000 patients and 212 000 single-cell profiles.
COVID-19 in Hemodialysis Patients: A Report of 5 Cases
TL;DR: Clinical and epidemiological features of COVID-19 in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan university, including 5 patients who contracted CO VID-19 disease are described and none of the patients had developed severe complications or died.
TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer.
Zimeng Wei,Xingruo Zeng,Yufei Lei,Hengjing He,Muhammad Jamal,Chengjie Zhang,Hai-Hua Tan,Songping Xie,Qiu-ying Zhang +8 more
TL;DR: TTYH3 was upregulated in lung cancer tissues compared to normal tissues and possessed a prominent diagnostic and prognostic value as discussed by the authors , which might provide new strategies like anti-ttyH3 combined with immune therapy for the treatment of lung cancer.